Home/Filings/4/0001127602-24-027277
4//SEC Filing

De Witte Jan 4

Accession 0001127602-24-027277

CIK 0000943819other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 11:49 AM ET

Size

4.4 KB

Accession

0001127602-24-027277

Insider Transaction Report

Form 4
Period: 2024-11-12
De Witte Jan
Director
Transactions
  • Sale

    ReMed Common Stock

    2024-11-12$248.81/sh796$198,0536,723 total
Footnotes (1)
  • [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001776929

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 11:49 AM ET
Size
4.4 KB